1. "2017"
  2. "Epidemiology and Biostatistics"
  3. "Lymphoma"
Formats
  1. Meeting Abstract (15)
  2. Journal Article (12)
Groups
  1. Center for Hematologic Malignancies (27)
  2. Department of Medicine (27)
  3. Epidemiology and Biostatistics (27)
  4. Hematologic Malignancies, Division of (27)
  5. Lymphoma (27)
  6. Biostatistics Service (25)

More Groups

People
  1. Matthew Matasar (19)
  2. Anas Younes (17)
  3. Andrew Zelenetz (17)
  4. Craig Moskowitz (17)
  5. Alison Moskowitz (13)
  6. Paul Hamlin (13)

More People

Years
  1. 2017 (27)
Publications
  1. Blood (7)
  2. Hematological Oncology (6)
  3. Journal of Clinical Oncology (3)
  4. Annals of Oncology (1)
  5. Biology of Blood and Marrow Transplantation (1)
  6. British Journal of Haematology (1)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. Wiley Blackwell (6)
  3. American Society of Clinical Oncology (3)
  4. Elsevier Inc. (3)
  5. American Association for Cancer Research (2)
  6. Oxford University Press (2)

More Publishers

Results (27)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early toxicities associated with radiation based conditioning for relapsed/refractory Hodgkin lymphoma patients undergoing high dose therapy and autologous stem cell transplantation (HDT-ASCT)
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Devlin, S. M.; Yahalom, J.; Matasar, M. J.; Moskowitz, A.; Giralt, S. A.; Moskowitz, C. H.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Phase I dose escalation of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and follicular lymphoma (FL)
    Meeting Abstract

    Batlevi, C. L.; Hamlin, P. A.; Matasar, M. J.; Horwitz, S. M.; Gerecitano, J. F.; Moskowitz, C. H.; Straus, D. J.; Zelenetz, A. D.; Drullinsky, P.; Copeland, A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A validated risk model for overall survival in relapsed/refractory chronic lymphocytic leukemia applicable to patients treated with novel therapies and standard of care
    Meeting Abstract

    Soumerai, J. D.; Ni, A.; Darif, M.; Londhe, A.; Xing, G.; Huang, J.; Lin, M.; Byrd, J. C.; Chanan-Khan, A. A.; Furman, R. R.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • A phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory B-and T-cell lymphomas
    Meeting Abstract

    Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M. A.; Lynch, P.; Scheuerman, M.; Minnal, V.; Galasso, N.; Kumar, A.; Gerecitano, J.; Zelenetz, A. D.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • A pilot study of brentuximab vedotin and AVD chemotherapy followed by 20 Gy involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Casulo, C.; Advani, R. H.; Budde, L.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Chen, R. W.; Constine, L. S.; Courtien, A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Genomic characteristics clinical phenotype and disease course of TP53 mutated diffuse large B cell lymphoma at diagnosis and relapse
    Meeting Abstract

    Joffe, E.; Batlevi, C. L.; Intlekofer, A. M.; Zelenetz, A. D.; Moskowitz, C. H.; Palomba, M. L.; Noy, A.; Straus, D. J.; Portlock, C. S.; Gerecitano, J.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Natural history of hypogammaglobulinemia in patients with follicular lymphoma and the impact of anti-CD20-based therapy
    Meeting Abstract

    Fischer, T.; Ni, A.; Soumerai, J. D.; Alperovich, A.; Batlevi, C. L.; Younes, A.; Zelenetz, A. D.
    Blood (2017)

    Fulltext@MSK | Save
  • Impact of PET staging of follicular lymphoma on treatment outcomes and prognosis
    Meeting Abstract

    Alperovich, A.; Batlevi, C. L.; Intlekofer, A. M.; Moskowitz, C. H.; Horwitz, S. M.; Zelenetz, A. D.; Palomba, M. L.; Moskowitz, A. J.; Gerecitano, J.; Hamlin, P. A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Preexisting cardiovascular risk and subsequent heart failure among non-Hodgkin lymphoma survivors
    Journal Article

    Salz, T.; Zabor, E. C.; de Nully Brown, P.; Oksberg Dalton, S.; Raghunathan, N. J.; Matasar, M. J.; Steingart, R.; Vickers, A. J.; Munksgaard, P. S.; Oeffinger, K. C.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Schòˆder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Cadzin, B. R.; Fox, S. Y.; Gerecitano, J.; more...
    Blood (2017)

    Fulltext@MSK | Save